Recently, we reported an increased incidence of soft tissue sarcomas in a biopsy population of cats at the University of Pennsylvania School of Veterinary Medicine.8 Epidemiologic evidence indicated that this increase coincided with enactment of a Pennsylvania state law requiring rabies vaccination of cats, and the majority of these sarcomas were in areas routinely used by veterinarians for vaccination (dorsal neck/ interscapular, dorsolateral thorax, hindlimb, dorsal lumbar). Many of the sarcomas were surrounded and partially infiltrated by an inflammatory infiltrate of lymphocytes and macrophages. A similar inflammatory infiltrate had previously been reported to occur subsequent to subcutaneous injection of rabies vaccines in cats and dogs.' Furthermore, aluminum was identified in macrophages surrounding the sarcomas by electron probe x-ray microanalysis. Aluminum, in the form of aluminum hydroxide or aluminum phosphate, is an adjuvant in approximately 20% of vaccines for feline use. It was our interpretation that persistence of the inflammatory and immunologic reactions associated with the presence of the aluminum in the vaccination sites predisposes the cat to a derangement of its fibrous connective tissue repair response, occasionally leading to neoplasia. It is now apparent that vaccine-associated sarcomas are being recognized throughout the United S t a t e~.~. '~ Here we describe the histology and immunohistochemical marker staining of postvaccinal sarcomas. We hope this will increase the recognition of these sarcomas by pathologists and shed some light on the pathogenesis of this intriguing syndrome.
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The information presented here is based on 46 feline sarcomas in the surgical pathology files of the School of Veterinary Medicine of the University of Pennsylvania. These sarcomas were received during 1991 and 1992 and were documented by Veterinarians responding to an epidemiological survey to have occurred at sites at which there had been previous vaccination (unpublished data). Sarcomas were fixed in 10% formalin and routinely processed for histologic examination. Five-micrometer sections were cut from paraffinembedded blocks and stained with hematoxylin and eosin. A previously described avidin-biotin immunoperoxidase complex technique was used on representative sarcoma^.^ Briefly, paraffin-embedded sections, 5 pm in thickness, were cut and carefully melted at 58-60 C. After deparaffinization and rehydration, slides were incubated in 0.3% H 2 0 2 in absolute methanol for 45 minutes. Sequential incubations in 20% normal goat serum (30 minutes), primary antiserum (1 hour at room temperature or overnight at 4 C), secondary biotinylated antibody (45 minutes), and avidin-biotin complex reagent (45 minutes) followed. Sections were then exposed to the chromagen reaction solution (0.035% diaminobenzidine in 10 ml Tris buffer, filtered, and brought to 0.03% H202) for 5 minutes. Sections were counterstained in Mayer's hematoxylin, dehydrated, cleared, and mounted.
For certain antisera (see below), sections were pretreated with a 0.1% solution of trypsin (Sigma Co., St. Louis, Missouri) in phosphate-buffered saline with 0.1% CaCl for 30 minutes at 37 C.
Sources of reagents and dilutions of antisera and modifications were as follows: avidin-biotin reagents (Vector Laboratory System, Burlingame, California); diaminobenzidine (Sigma Co.); antibody to cytokeratin (1 / 100, trypsinized, Lab Systems, Chicago, Illinois); desmin (1/450,2 hour room temperature; Dako, Santa Barbara, California); vimentin (1/20, Dako); muscle-specific actin (MSA, 1/4,000, Enzo, New York, New York); smooth muscle actin (SMA, 1/50, Dako); Factor VIII antigen (1/750, trypsinized, Dako); SlOO antigen (1/1,000, Dako); Factor 13a (1/1,000, Dako); epithelial membrane antigen (EMA, 1/50, Dako); and antibody to CD34 (1/25, Becton-Dickinson, Rutherford, New Jersey).
Both negative and substitution serum controls and positive tissue controls were employed.
A photograph of a post-vaccinal sarcoma in the thigh of a cat is shown in Fig. 1 . The majority of the tumors were well demarcated and some were partially encapsulated. Those in the subcutis of the dorsal neck or thorax were often just ventral to and/or continuous with the panniculus carnosus muscle (Fig. 2) . Histologically, the 46 post-vaccinal sarcomas included fibrosarcomas (23), malignant fibrous histiocytomas (1 3), osteosarcomas (7) , rhabdomyosarcomas (2), and chondrosarcoma (1) . Fibrosarcomas (FSA) and malignant fibrous histiocytomas (MFH) made up the bulk ofthe tumors, and there was much overlap between fibrosarcomas with giant cells (6/23) and MFH. The majority ofthe post-vaccinal tumors had spindle cells, multinucleated giant cells, and variable numbers of pleomorphic polygonal to histiocytoid cells with mild to marked atypia. This morphologic description might be diagnosed as different sarcomas by different pathologists. We chose to call those tumors fibrosarcomas in which the spindle cells were predominant and arranged in long fascicles (Fig. 3) , and those MFH in which there was more of a storiform arrangement of spindle cells and a preponderance of the atypical histiocytoid cells (Fig. 4) . These atypical histiocytoid cells are central to the diagnosis of MFH and are not found in fibrosarcomas of animals or humans.6 Many tumors had identical morphology to FSA or MFH except that there were occasional microscopic foci of neoplastic osteoid and/or bone. These tumors were designated as osteosarcomas. One tumor was composed of sheets of round to polygonal cells within lacunae surrounded by a light blue matrix consistent with cartilage; this tumor was diagnosed as chondrosarcoma ( Fig. 5) . Two tumors were very distinctive, with nests of round cells with large round nuclei and moderate light pink cytoplasm (Fig. 6) . These cells were thought to look like rhabdomyoblasts and therefore compatible with poorly differentiated rhabdomyosarcoma.
Immunohistochemical marker staining results of five representative sarcomas are listed in Table 1 . Nearly all cases contained immunoreactive vimentin, the mesenchymal cell intermediate filament. In addition, four cases showed immunoreactivity for one or more muscle markers (desmin, muscle-specific actin [HHF 351, or smooth muscle actin). This pattern of reactivity, namely vimentin-positive and muscle marker-positive cells, is consistent with reactivity of myofibroblasts. The chondrosarcoma case was floridly positive for SlOO protein, consistent with that diagnosis. The strong desmin positivity supports but does not prove a diagnosis of rhabdomyosarcoma in case no. 5. All other markers including cytokeratin, EMA, CD34, factor VIII-related antigen and factor 13a were negative. Internal positive controls were identified in the sections of most of the tumors, with the exception of EMA and CD34.
The histologic appearance and immunohistochemical marker staining of the majority of tumors are consistent with a fibroblastic/myofibroblastic phenotype. The exact origin of myofibroblasts is controversial, but many believe they represent a "transitional stage" through which fibroblasts or even macrophages pass during the process of wound healing.5 Fibroblasts and myofibroblasts are therefore considered integral to tissue repair. Several authors have proposed that MFH in humans originates from neoplastic transformation of these myofibroblasts in transition.' Tumors with similar histologic variability have previously been described arising in the eyes of cats following previous and/or persistent trauma.* One recently reported post-vaccinal sarcoma had immunohistochemical marker staining consistent with a myofibroblastic phenotype and was called a "myofibrosarcoma" by the authors.' The finding of chondrosarcoma or osteosarcoma in an area of chronic inflammation is not new, nor should it be surprising. Pathologists and others have long recognized metaplastic cartilage and/or bone in areas of previous trauma or chronic irritation. It is thought that these lesions result from transformation of proliferating primitive or undifferentiated mesenchymal cells at the site due to unknown factors. Neoplasms in this setting may be due to transformation of the the undifferentiated mesenchymal cells or the metaplastic cartilage or bone.
By strict criteria, the neoplasm in case no. 5 cannot legitimately be called a rhabdomyosarcoma based on the features described above. Electron microscopy was attempted on paraffin-embedded tissue, but cellular preservation was poor. We could recognize that the cytoplasm of the round rhabdomyoblast-like cells were full of swirls of filaments, but we were unable to find any evidence of Z-band material. The strong desmin staining supports a muscle origin, and the histologic appearance was compatible with a skeletal, not smooth, muscle tumor. Whatever we choose to call this tumor, it and the others presented here represent a spectrum of sarcomas that could arise from fibroblasts, myofibroblasts, and other undifferentiated mesenchymal cells that proliferate in areas of chronic inflammation and/or wound healing. This lends support to the hypothesis that the persistent inflam- matory and immunologic reactions to aluminum adjuvants (or some other vaccine component) induce continued proliferation of resident mesenchymal cells that may, in some cases, lead to neoplastic transformation of these cells.
